Balux, UAB was founded in 2010 in Vilnius, Lithuania. Since then we had one main direction – to be a specialized niche transporter of temperature sensitive pharmaceuticals. With operations around the clock, 365 days a year, we provide solutions suitable to fit your needs.
Today we can say, that 100% of our deliveries are pharmaceuticals. From truck features, to written procedures; from staff trainings to IT systems we are improving every year that our customers with specific needs would receive customized solutions.
Our vehicles which all are temperature controlled, fully calibrated could safely store both – ambient and cold chain products. They are GPS tracked, have remote temperature monitoring and functioning to GDP guidelines, ensuring safe transit and delivery of all products. Anyway, when it comes to quality transport of pharmaceutical products is not just a question of equipment. Safe and sound delivery is also dependent on a highly trained team. All of our staff members, from drivers, to administrative personnel are trained to the specific needs of the pharmaceutical sector.
In addition to full documenting all transports, our experienced managers maintain regular contact with drivers to ensure the exact temperature monitoring of highly temperature-sensitive pharmaceuticals, as protecting your products is our highest priority.
Mission:
Ensure safe pharmaceutical movement.
Vision:
The first choice of high-value medicines transport.
Values:
Flexibility
Continuous Improvement
Ethical business practices
Partnership
Contact:
Address: Balux, UAB Kalvariju str. 125, 20 unit LT-08221, Vilnius, Lithuania
Tel. +370 5 207 23 39
Website: http://balux.lt/
As the Lithuanian market matures, profound shifts have been taking place in the arena of human resources and how drug developers go about identifying, acquiring and retaining the personnel they…
Lukas Savickas, advisor to the prime minister of Lithuania, highlights the changes needed for the Lithuanian life science industry to become more competitive, while discussing the opportunities awaiting companies willing…
With over 120,000 people whose lives are affected by the disease in Lithuania; diabetes stands as one of the country’s major health issues today. Furthermore, as Marijus Valatka, general manager…
Lithuania’s biotech sector has grown by between 20 and 25 percent over the last five years and accounts for over one percent of the entire country’s GDP. Key industry stakeholders…
Aki Kasvi and Mindaugas Plieskis of Janssen Baltics discuss their strategic priorities, acting as a strategic partner within the region, and ensuring that patients can access their innovative latest-generation therapies…
Eugenija Sutkienė of TGS Baltic, a commercial law firm operating across the Baltics, discusses the services that the organization provides to the pharmaceutical and biotech industries and what sets them…
Dr. Rasa Verkauskiene, a key opinion leader in endocrinology in Lithuania, discusses the levels of diabetes in the country and how various stakeholders are working together to combat what is…
Daina Klepone, managing director at Enterprise Lithuania, explains the opportunities Lithuania can offer to healthcare businesses and how their organization can help them enter the market. Moreover, she introduces the…
Vytautas Baublys, co-founder and CEO of Softneta, introduces the award-winning Lithuanian IT company, and its service offering, explaining how software-based specialized healthcare solutions improve the quality of patient care. Further,…
Jūratė Sabalienė, who was appointed in September 2017 as the director of the National Health Insurance Fund (NHIF) of the Republic of Lithuania, explains her commitment as well as the…
Šarūnas Keserauskas, chairman of the Lithuanian Competition Council (KT), discusses his decision to return to Lithuania from the UK, EU collaboration, and the level of competition within Lithuania’s healthcare and…
Zydrune Visiockene, head of Vilnius University’s Center of Endocrinology and a key opinion leader on the topic of diabetes in the Baltics, casts his expert eye over the disease’s prevalence…
See our Cookie Privacy Policy Here
